Search - tctmd.com

Displaying 321 - 340 of 435

Sort: Relevancy | Date

News Daily News

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

L.A. McKeown

August 19, 2015

News Industry News

Biotronik launches 2 new studies

August 13, 2015

News Daily News

Pulmonary Hypertension Type Predicts TAVR Outcome, Could Help Select Candidates

Yael L. Maxwell

August 05, 2015

News Daily News

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

L.A. McKeown

August 03, 2015

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Todd Neale

July 27, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

Poor Mobility Strongly Predicts Mortality in TAVR Patients

Yael L. Maxwell

July 06, 2015

News Daily News

CTOs Relatively Frequent in Patients Without Previously Known CAD

Nicole Lou

June 30, 2015

News Daily News

Las OTC son Relativamente Frecuentes en Pacientes Sin EAC Conocida Anteriormente

Nicole Lou

June 30, 2015

News Daily News

Study Explores Safety of Early Discharge After Transfemoral TAVR

L.A. McKeown

June 24, 2015

News Daily News

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Caitlin E. Cox

June 15, 2015

News Daily News

LV Flow After TAVR Predicts Late Mortality

June 11, 2015

News Daily News

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Yael L. Maxwell

June 03, 2015

News Daily News

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

Caitlin E. Cox

May 29, 2015

News Industry News

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

May 20, 2015

News Daily News

FRANCE 2: Prior CABG Does Not Influence Mortality After TAVR

Todd Neale

May 18, 2015

News Daily News

Melody 瓣膜的长期结局良好，特别是当其与支架先行置入同时实施时

Todd Neale

May 14, 2015

Advertisement

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

Biotronik launches 2 new studies

Pulmonary Hypertension Type Predicts TAVR Outcome, Could Help Select Candidates

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

Poor Mobility Strongly Predicts Mortality in TAVR Patients

CTOs Relatively Frequent in Patients Without Previously Known CAD

Las OTC son Relativamente Frecuentes en Pacientes Sin EAC Conocida Anteriormente

Study Explores Safety of Early Discharge After Transfemoral TAVR

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

LV Flow After TAVR Predicts Late Mortality

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

FRANCE 2: Prior CABG Does Not Influence Mortality After TAVR

Melody 瓣膜的长期结局良好，特别是当其与支架先行置入同时实施时

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content